Evidence map›Paper›PMID 34202201›Full record

ReviewBiomedicines2021

HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity.

Arianna Bonizzi, Gabriele Piuri, Fabio Corsi, Roberta Cazzola, Serena Mazzucchelli

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Dysfunctional high-density lipoprotein: an updated review.Frontiers in cardiovascular medicine · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Arianna BonizziDepartment of Biomedical and Clinical Sciences "L. Sacco", Università di Milano, 20157 Milan, Italy.ORCID 0000-0002-5948-8747
Gabriele PiuriDepartment of Biomedical and Clinical Sciences "L. Sacco", Università di Milano, 20157 Milan, Italy.ORCID 0000-0002-2925-3007
Fabio CorsiDepartment of Biomedical and Clinical Sciences "L. Sacco", Università di Milano, 20157 Milan, Italy.ORCID 0000-0002-6469-4086
Roberta CazzolaDepartment of Biomedical and Clinical Sciences "L. Sacco", Università di Milano, 20157 Milan, Italy.ORCID 0000-0002-0778-8529
Serena MazzucchelliDepartment of Biomedical and Clinical Sciences "L. Sacco", Università di Milano, 20157 Milan, Italy.ORCID 0000-0001-6904-8895
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-density lipoproteins (HDLs) represent a class of lipoproteins very heterogeneous in structure, composition, and biological functions, which carry out reverse cholesterol transport, antioxidant, anti-inflammatory, antithrombotic, and vasodilator actions. Despite the evidence suggesting a clear inverse relationship between HDL cholesterol (HDL-c) concentration and the risk for cardiovascular disease, plasma HDL cholesterol levels do not predict the functionality and composition of HDLs. The importance of defining both the amount of cholesterol transported and lipoprotein functionality has recently been highlighted. Indeed, different clinical conditions such as obesity, diabetes mellitus type 2 (T2DM), and cardiovascular disease (CVD) can alter the HDL functionality, converting normal HDLs into dysfunctional ones, undergoing structural changes, and exhibiting proinflammatory, pro-oxidant, prothrombotic, and proapoptotic properties. The aim of the current review is to summarize the actual knowledge concerning the physical-chemical alteration of HDLs related to their functions, which have been found to be relevant in several pathological conditions associated with systemic inflammation and oxidative stress.

Indexed as

cardiovascular diseasediabetes mellitus type 2dysfunctional HDLHDL cholesterolhigh-density lipoproteinsobesity

Identifiers

PMID34202201
PMCPMC8301425
OpenAlexW3173201428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.